KV Pharmaceuticals has fought, and failed, on multiple fronts to capitalize on a drug used to prevent preterm births known as Makena.
Now the bankrupt drug maker is turning to Utah Attorney General John Swallow in a bid to strike a Medicaid policy favoring KV’s competitors — compounding pharmacies that make the drug for pennies on the dollar.
Pointing to the deadly meningitis outbreak caused late last year by products compounded by a pharmacy in New England, Christmas suggests Utah should more tightly regulate compounders.
"In violation of Utah law, compounding pharmacies continue to make and distribute large volumes of … copies, or essential copies of Makena," alleged KV vice president Patricia Christmas in a letter preceding a private meeting on Tuesday with Swallow.
Continue to read here
No comments:
Post a Comment